R&D channel feed – Endpoints News

R&D channel feed

Lykos’ pain is others’ gain as psychedelic biotechs take notes from adcomm vote

11 months ago

Amylyx, searching for post-ALS future, licenses a GLP-1 drug

11 months ago

Altimmune says ‘double G’ drug has even better lean mass preservation data in obesity trial update

11 months ago

Alnylam’s RNAi therapy succeeds in closely-watched Phase 3 heart trial

11 months ago

Fractyl pitches potential of GLP-1 gene therapy, but pushes clinical trials back to 2025

11 months ago

Three of Vertex’s islet cell therapy patients go insulin-independent

11 months ago

Lilly’s Zepbound resolves sleep apnea in obese patients, furthering case for label expansion

11 months ago

Gilead's twice-a-year injection fully prevented HIV in Phase 3 study with cisgender women

11 months ago

Scientists just discovered a new genetic clue for delaying Alzheimer’s disease. It’s already inspiring drug discovery

11 months ago

Zealand Pharma hits early efficacy goal for amylin weight loss candidate

11 months ago

Jazz's stock dips after mid-stage fail in essential tremor

11 months ago

PTC touts Phase 2 biomarker data for Huntington’s drug, showing dose-dependent effect at one year

11 months ago

Silence’s siRNA candidate for cardiovascular disease continues to deliver in Phase 2 trial

11 months ago

Aphaia hits primary endpoint with oral glucose drug in mid-stage prediabetes trial

11 months ago

iOnctura raises €80M to advance early-stage rare eye cancer treatment

11 months ago

Intra-Cellular reports a depression win, setting up future competition with AbbVie's Vraylar

11 months ago

Updated: Taysha teases early gene therapy data for Rett syndrome

11 months ago

After two patient deaths from presumed sepsis, FDA puts partial hold on Zentalis studies

11 months ago

AstraZeneca’s Truqap combo flops in Phase 3 triple-negative breast cancer trial

11 months ago

GSK readies Blenrep's commercial re-launch in the US, and a push in second line

11 months ago

J&J cements footprint in Italy with €580M in investments over the next 5 years

11 months ago

Updated: FDA places partial hold on BioNTech-MediLink ADC after multiple deaths

11 months ago

J&J’s Sjögren’s disease drug shows promise in Phase 2, boosts prospects of FcRn assets in the autoimmune disease

11 months ago

Marinus reports mixed Phase 3 results on IV seizure drug

11 months ago

First page Previous page 39 40 414243 44 45 Next page Last page